1
|
Del Fabro V, Di Giorgio MA, Leotta V, Duminuco A, Bellofiore C, Markovic U, Romano A, Bulla A, Curto Pelle A, Elia F, Di Raimondo F, Conticello C. Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study. Cancers (Basel) 2023; 15:4036. [PMID: 37627065 PMCID: PMC10452433 DOI: 10.3390/cancers15164036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 08/03/2023] [Accepted: 08/08/2023] [Indexed: 08/27/2023] Open
Abstract
Based on the results obtained in clinical trials, the use of the combination of lenalidomide and dexamethasone (Len/Dex) has become a potential therapeutic choice for newly diagnosed multiple myeloma (NDMM) ineligible for autologous stem cell transplantation. This study evaluated 89 frail NDMM patients treated with first-line oral association. At the last follow-up, 34 out of 89 patients (38.2%) were alive, and 22 were still in treatment with Len/Dex. Among 73 evaluable patients who received at least two cycles, the overall response rate was 71% (N = 52). The disease control rate, defined as any level of clinical response to therapy, occurred in 71 patients (97%). We reported one or more adverse events of grade 3 or 4 (G3/4) in 65.2% (N = 58) of patients, with a prevalence of hematological toxicity (24 patients), leading to an overall discontinuation of treatment in two cases. In univariate analysis, high ISS, high serum β2-microglobulin, and creatinine clearance <30 mL/min negatively impact OS, while the depth of response positively impacts OS. Moreover, G3-4 anemia, ISS, frailty score, and ECOG negatively impacts PFS. In conclusion, elderly and more frail patients benefit from the Len/Dex combination also in the era of monoclonal antibodies, ensuring an increased PFS and OS in patients where the therapeutic choice is often limited and usually not very effective.
Collapse
Affiliation(s)
- Vittorio Del Fabro
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| | - Mary Ann Di Giorgio
- Division of Hematology, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, 95122 Catania, Italy; (M.A.D.G.); (V.L.); (C.B.)
| | - Valerio Leotta
- Division of Hematology, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, 95122 Catania, Italy; (M.A.D.G.); (V.L.); (C.B.)
| | - Andrea Duminuco
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| | - Claudia Bellofiore
- Division of Hematology, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, 95122 Catania, Italy; (M.A.D.G.); (V.L.); (C.B.)
- Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Matteo, 27100 Pavia, Italy
| | - Uros Markovic
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| | - Alessandra Romano
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
- Dipartimento di Chirurgia Generale e Specialità Medico Chirurgiche, University of Catania, 95123 Catania, Italy
| | - Anna Bulla
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| | - Angelo Curto Pelle
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| | - Federica Elia
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| | - Francesco Di Raimondo
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
- Dipartimento di Chirurgia Generale e Specialità Medico Chirurgiche, University of Catania, 95123 Catania, Italy
| | - Concetta Conticello
- Division of Hematology with BMT, A.O.U. Policlinico “G.Rodolico-San Marco”, 95123 Catania, Italy; (U.M.); (A.R.); (A.B.); (A.C.P.); (F.E.); (F.D.R.); (C.C.)
| |
Collapse
|